학술논문
Ipilimumab and nivolumab: the 'new kid on the block' in advanced angiosarcoma.
Document Type
Editorial
Source
Immunotherapy (1750743X); Oct2023, Vol. 15 Issue 14, p1089-1091, 3p
Subject
Language
ISSN
1750743X